1. Home
  2. BRR vs TNYA Comparison

BRR vs TNYA Comparison

Compare BRR & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BRR

Columbus Circle Capital Corp I Class A Ordinary Shares

N/A

Current Price

$1.77

Market Cap

174.8M

Sector

Finance

ML Signal

N/A

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

N/A

Current Price

$0.78

Market Cap

168.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BRR
TNYA
Founded
2024
2016
Country
United States
United States
Employees
5
70
Industry
Blank Checks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
174.8M
168.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BRR
TNYA
Price
$1.77
$0.78
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.33
AVG Volume (30 Days)
987.6K
2.5M
Earning Date
06-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.96
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$0.53
52 Week High
$10.51
$2.35

Technical Indicators

Market Signals
Indicator
BRR
TNYA
Relative Strength Index (RSI) 51.53 43.62
Support Level $1.41 $0.65
Resistance Level $2.13 $0.80
Average True Range (ATR) 0.17 0.05
MACD 0.01 -0.01
Stochastic Oscillator 52.05 7.66

Price Performance

Historical Comparison
BRR
TNYA

About BRR Columbus Circle Capital Corp I Class A Ordinary Shares

ProCap Financial Inc is focused on Bitcoin-focused media products and Bitcoin holdings. The Company typically provides advertising and marketing services through weekly digital media placements, including audio and social media advertisements. The Company offers media products to help independent investors understand financial markets, current events, and technology advancements. These media products include social media accounts, email newsletters, and audio or video content. The Company also added strategies related to the use of AI and automation to support the development and delivery of financial products and services.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: